billHR8324Event Thursday, April 16, 2026Analyzed

Great American Healthcare Plan

Bullish

Summary

HR8324 (Great American Healthcare Plan) is an early-stage bill expanding HSA contribution limits and eligible expenses. It has no direct funding and faces a long legislative path. The primary market impact is a structural shift toward HDHPs, benefiting HSA administrators and retail pharmacies while pressuring traditional insurance premium revenue.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR8324 is an early-stage bill with zero direct funding and low near-term passage probability.
  • 2.HSA expansion favors insurers with strong HDHP products (HUM, ANTM) and retail pharmacies (CVS).
  • 3.The bill's seven-committee referral indicates jurisdictional complexity and low momentum.

Market Implications

The immediate market impact is negligible given the bill's early stage. If the bill advances, expect relative outperformance of HDHP-focused insurers ($HUM, ) over Medicaid-heavy peers. CVS Health ($CVS) benefits from retail pharmacy sales of newly eligible HSA items. No real market data is available for price trends.

Full Analysis

1) What happened: On April 16, 2026, Rep. Burlison (R-MO) introduced HR8324, the Great American Healthcare Plan. The bill was referred to seven committees (Energy & Commerce, Ways & Means, Education & Workforce, Judiciary, Armed Services, Veterans' Affairs, Foreign Affairs) — an unusually broad referral indicating jurisdictional complexity. As of May 18, 2026, the bill remains in committee with no further action. It is an early-stage bill with low near-term passage probability. 2) The money trail: HR8324 authorizes zero direct spending. It is a tax and regulatory reform bill, not an appropriations bill. The primary mechanism is amending the Internal Revenue Code (IRC §223) to increase HSA contribution limits and expand eligible expenses to include health insurance premiums, direct primary care, healthy food, vitamins, dietary supplements, sports/fitness expenses, and health care sharing ministry payments. It also allows HSA rollovers to children/parents, charitable contributions to HSAs, and rollovers from FSAs/HRAs. These changes reduce federal tax revenue (by allowing more pre-tax HSA contributions) but do not allocate funds to any entity. 3) Structural winners and losers: Winners include HSA administrators (banks, credit unions, financial firms like Optum Bank/UNH), retail pharmacies (CVS/CVS Health) that sell newly eligible items, and health insurers with strong HDHP product lines (HUM, ANTM). Losers include insurers with heavy traditional plan exposure (CNC's commercial segment is small; UNH's UnitedHealthcare faces premium erosion but Optum offsets). The hospital price transparency provisions (Title III) are separate but impose compliance costs on hospitals and insurers — no specific tickers are directly named. 4) Competitive landscape: The bill's HSA expansion favors insurers with established HDHP/HSA products (HUM, ANTM) over those focused on Medicaid/Medicare (CNC). CVS Health benefits uniquely from retail pharmacy sales of newly eligible items. UNH is a mixed bag: premium erosion at UnitedHealthcare vs. fee growth at Optum Bank. No real market data is provided for price trends. 5) Timeline: The bill is at the earliest legislative stage. It must pass through seven committees (each with jurisdiction over different provisions), then the House floor, then the Senate, then be signed by the President. Given the 119th Congress (2025-2027) is in its second session, the window for passage is narrow. The bill's broad referral and lack of Senate companion suggest low momentum. Passage probability is below 10% in the current Congress.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Unconfirmed

No confirming evidence found yet from contracts, insider trades, or congressional activity

$$UNH● Neutral
Est. $-500,000,000$200.0M revenue impact

What the bill does

Expansion of HSA contribution limits and eligible expenses (including health insurance premiums, direct primary care, healthy food, vitamins, supplements, sports/fitness) via amendments to IRC §223 and related sections.

Who must act

Employers offering HDHPs and HSA-eligible plans; HSA administrators (banks, credit unions, financial institutions); health insurers selling individual/group plans.

What happens

Increased HSA contribution limits and broader eligible expense definitions shift consumer healthcare spending from insurance premiums to out-of-pocket HSA-funded expenses, reducing premium revenue for insurers but increasing HSA administration fee income for financial firms.

Stock impact

UnitedHealth Group's UnitedHealthcare segment faces premium revenue pressure as HSA expansion incentivizes HDHP enrollment over traditional plans; however, Optum's HSA administration business (Optum Bank) gains fee income from higher contribution volumes and new eligible expense categories. Net effect is mixed: premium erosion partially offset by HSA fee growth.

$$HUM▲ Bullish
Est. $100.0M$400.0M revenue impact

What the bill does

Same HSA expansion provisions as above; Humana is a major Medicare Advantage and individual health insurer with significant HDHP/HSA product offerings.

Who must act

Employers and individuals purchasing Humana's HDHP/HSA plans; Humana's HSA administration services.

What happens

Higher HSA contribution limits and broader eligible expenses increase attractiveness of HDHPs, potentially shifting enrollment from traditional plans to HDHPs. Humana's HSA-linked products benefit from increased contributions, but premium revenue from non-HDHP plans may decline.

Stock impact

Humana's individual and group health insurance segments see premium mix shift toward HDHPs; HSA administration fees rise. Net impact is modestly positive due to Humana's strong HDHP market position and lower exposure to fully insured commercial business compared to peers.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderMay 19, 2026

Restoring Integrity to America’s Financial System

This executive order directs the Treasury Department to issue an advisory to financial institutions on risks from non-work authorized populations and their employers, propose regulatory changes to strengthen Bank Secrecy Act customer due diligence and identification requirements, and consider risks from foreign consular IDs. It also directs the CFPB to clarify that deportation risk can affect ability-to-repay assessments for non-work authorized borrowers, and federal financial regulators to issue guidance on credit risks from this population.

Exec OrderMay 19, 2026

Integrating Financial Technology Innovation into Regulatory Frameworks

This executive order directs federal financial regulators to review and streamline regulations that hinder fintech innovation, particularly for small and emerging firms, and requests the Federal Reserve to evaluate expanding access to its payment accounts and services for non-bank and digital asset firms. It aims to reduce barriers to entry and encourage partnerships between fintech firms and traditional financial institutions, with specific deadlines for reviews and reports.

Exec OrderMay 1, 2026

Imposing Sanctions on Those Responsible for Repression in Cuba and for Threats to United States National Security and Foreign Policy

This Executive Order expands the existing national emergency against the Government of Cuba by imposing broad secondary sanctions and asset freezes on foreign persons operating in key sectors of the Cuban economy (energy, defense, metals/mining, financial services, security). It authorizes the Treasury and State Departments to block property and deny entry to individuals and entities involved in repression, corruption, or support for the Cuban government, and empowers Treasury to sanction foreign financial institutions that facilitate transactions for designated persons. The order effectively tightens the U.S. embargo by targeting third-country companies and banks that do business with Cuba.